Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.
Guo C, Martinez-Vasquez D, Mendez GP, Toniolo MF, Yao TM, Oestreicher EM, Kikuchi T, Lapointe N, Pojoga L, Williams GH, Ricchiuti V, Adler GK.
Endocrinology. 2006 Nov;147(11):5363-73. Epub 2006 Aug 10.PMID: 16901964 [PubMed - indexed for MEDLINE]Related articlesFree article